Strategic Growth AI accelerates market entry for life sciences and AI-health ventures in Canada and the United States.
We reduce launch risk and compress time to reimbursement by aligning regulatory, market access, and go-to-market strategy from the outset.
Our difference, clarity and execution you can count on:
Regulatory‑First Planning
We start with approvals and compliance, so you don’t hit roadblocks later
Payer‑Ready Proof
Every pilot and study is designed to satisfy payers’ evidence needs for reimbursement
Operators, Not Just Advisors
Seasoned execs (40+ launches) on your team, driving execution hand-in-hand
Investor‑Grade Metrics
Proprietary Clarity Intelligence™ models (rNPV, Monte Carlo) turn risk into numbers investors trust
From pre-market strategy to post-launch growth, we’ve got you covered.
Market Entry & Reimbursement
-
Enter Canada & U.S. markets with confidence
-
regulatory approvals and payer coverage from Day 1
Regulatory Pathway & AI Governance
-
Navigate FDA/Health Canada and ensure SaMD compliance while managing AI risk and bias
AI Deployment & Integration
-
Turn pilot projects into full-scale deployments
-
We integrate AI into clinical workflows for high adoption
Fractional Leadership & B.O.T.
-
Fill critical roles with interim experts
-
We Build-Operate-Transfer commercialization functions to accelerate traction
Investor Readiness & Valuation
-
Secure funding with investor-grade financial models and evidence
-
We boost your deal confidence and valuation
1. Rare Disease Launch
From Zero to National Leader
A global pharmaceutical company lacked any Canadian presence. We built their entire operation, regulatory, PSP, commercial and delivered their top-performing affiliate worldwide.
Outcome: Local success contributed to the company’s eventual strategic acquisition (post-engagement).
2. Digital Health Platform
Scaled to Exit
A continuing health education platform faced low physician adoption and exit risk. We rebuilt the GTM strategy, secured KOL support, and drove significant user growth.
Outcome: Acquired by a healthcare provider
3. Diagnostics Challenger
National Market Entry
Assisted a U.S. diagnostics firm break into a market long dominated by a single player. Through tailored regulatory strategy, compliance navigation, and operational execution, we supported rapid expansion across Canada.
Outcome: The company became one of the fastest-scaling diagnostics providers in the country, establishing a trusted national footprint in under 18 months.
1. What types of companies do you work with?
We partner with innovative AI-health, digital health, medtech, biotech ventures
-
Typically Seed A to Enterprise, as well as their investors.
-
If you’re in health and pushing new tech, we can likely help.
2. How are you different from other consultants?
We’re operator-led: our team members have built and run companies, so we execute (or even step in as interim execs) rather than just give advice.
-
Everything we recommend is backed by data and real-world evidence
3. Do you guarantee results?
We guarantee we’ll bring proven processes and work alongside you, skin in the game. But outcomes depend on many factors – we won’t promise “X revenue in Y months.” (No firm can.)
What we do is stack the odds in your favor – clients have seen up to 60% higher success rates using our de-risking methods.)
4.What is “Regulatory-first” and why does it matter?
It means we tackle regulatory and compliance hurdles early, not as an afterthought. For example, we align trials with what FDA or Health Canada needs, so you don’t have to redo work. This saves time, money, and often makes investors and partners more confident since they see a clear path to approval.
5. How soon can we start seeing value?
Quickly – in our kickoff Clarity Sprint (usually ~4–6 weeks), we’ll deliver key insights: a regulatory roadmap, a rough rNPV valuation, priority target segments, etc. Many clients get actionable recommendations in the first month. We aim for quick wins (like identifying a quick path to revenue) while laying the foundation for long-term success.